eli lilly retatrutide trial Phase 3 obesity results 2026 eli lilly retatrutide lawsuit The

Ozempic and type 2 diabetes In the SUSTAIN 1 trial (NCT02054897), 73% of people with type 2 diabetes taking Ozempic 0.5 mg injection reached an A1C of 7% or less within 30 weeks

Dose escalation beyond the receptor saturation threshold increases systemic exposure, raises the risk of off-target effects (HGF receptors exist in liver, kidney, and vascular tissue), and wastes expensive research compounds

As more people use GLP-1 medications for weight loss and metabolic health, expectations around food have changed, too

A 300-calorie dinner with 30 grams of protein beats a 600-calorie dinner you cannot finish

System xc - consists of SLC3A2 and SLC7A11 (xCT), which exchange extracellular cysteine for intracellular glutamate